Kazimierz Wisniewski,Geoffrey S. Harris,Robert Galyean
申请号：
US14534007
公开号：
US09388214B2
申请日:
2014.11.05
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Compounds of formula (I), salts thereof, and compositions and uses thereof are described. The compounds are useful as V1a vasopressin agonists, for the treatment of, e.g., complications of cirrhosis, including bacterial peritonitis, HRS2 and refractory ascites.
